Picture of mother (Susan) and daughter (Holly) smiling whilst sat next to each other on a train

The concern of passing on a genetic condition to a child can be very worrying. But getting involved in research has shown Moorfields patient Susan how bright the future is.

A concerning diagnosis

For loving mum Susan, her first thought upon being diagnosed with Fuchs Endothelial Corneal Dystrophy (FECD) was not for herself but for her daughter Holly.

Susan had noticed her vision had often been blurry when waking up and felt like the severity was increasing as time went on. 

A few appointments later, she was ultimately diagnosed with FECD, a condition she now knows could one day be inherited by Holly.

A determined response

After the initial shock of the diagnosis, Susan was determined to learn more about the condition and how she could help herself and Holly.

While looking online, she came across the work of Dr Alice Davidson at the UCL Institute of Ophthalmology (UCL), partially supported by the wonderful generosity of Moorfields Eye Charity donors.

Dr Davidson working in her lab at the UCL Institute of Ophthalmology

Dr Davidson and her team investigate the genetic secrets behind conditions like FECD. By understanding why genetic mutations occur, they hope to develop targeted gene therapies to treat several conditions.

We envisage that in the next 5 to 10 years, gene-directed therapies could move from pre-clinical research to clinical trials and even patient care.

Dr Alice Davidson - UCL Institute of Ophthalmology

How to get involved with research at Moorfields

Learn more

Moorfields invite patients interested in taking part in research studies to sign-up on their website below.

A brighter future

Susan was blown away by the dedication of Dr Davidson and her team and their fantastic progress towards helping patients like her.

It’s amazing what Dr Davidson and her team are doing - unravelling the genetics behind our eyesight. It will benefit us all.

Susan

Soon, Susan was participating in research studies at Moorfields, which Holly was also incredibly excited to help with. They discovered how crucial patient participation is to ground-breaking research like Dr Davidson’s.

From a place of trepidation, Susan’s involvement with research and supporting Moorfields has offered reassurance that brilliant researchers are working every day to help create a brighter future for FECD patients.

Breakthroughs into conditions like FECD are closer today than ever before. This is thanks to the dedication of researchers like Dr Davidson and amazing people like Susan and Holly.

Finding a treatment for mum’s condition means everything to me.

Holly, Susan’s daughter